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Triton X-100Resveratrol is a polyphenol compoundwith great value in cancer therapy, cardiovascular protection, and neuro-
degenerative disorders. The mechanism by which resveratrol exerts such pleiotropic effects is not yet clear and
there is a huge need to understand the inﬂuence of this compound on the regulation of lipid domains formation
on membrane structure. The aim of the present study was to reveal potential molecular interactions between
resveratrol and lipid rafts found in cell membranes by means of Förster resonance energy transfer, DPH ﬂuores-
cence quenching, and triton X-100 detergent resistance assay. Liposomes composed of egg phosphatidylcholine,
cholesterol, and sphingomyelin were used as model membranes. The results revealed that resveratrol induces
phase separation and formation of liquid-ordered domains in bilayer structures. The formation of such tightly
packed lipid rafts is important for different signal transduction pathways, through the regulation of membrane-
associating proteins, that can justify several pharmacological activities of this compound.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Resveratrol is a polyphenol compound present in grape skin and
seeds that is pointed out as a possible contributor to the cancer therapy,
antioxidant activity, cardiovascular protection, and neurodegenerative
diseases treatment [1,2]. In this study, we were interested in under-
standing the way by which resveratrol exerts such therapeutic effects
in a membrane molecular level, since some drugs act through a
membrane-lipid therapy, modulating the structure of lipid bilayers,
thereby inﬂuencing proteins activity and cellular processes [3–5]. Particu-
larly, domains formationhas been shown to be relevant in biological func-
tions which is closely related to dynamic coexisting ordered/disordered
domains and membrane microheterogeneity [6]. Membrane rafts are
lipid domains rich in cholesterol and sphingomyelinmolecules which as-
semble in amore ordered state, the liquid-orderedphase (lo), dispersed in
the bulkmembrane in liquid-disordered (ld) phase [7–9]. lo phase is char-
acterized by tight acyl chain packing, but relatively rapid lateral mobility
within the lipid bilayer [10]. The tight packing between sterol and
sphingolipids allows the formation of lo domains [11,12]. Several studies
have shown that lipid rafts play a critical role in proteins sorting, cell sig-
nalling and membrane trafﬁcking inside the cell [13–16]. Therefore, the
inﬂuence of resveratrol on the regulation of lipid domains formation
and stability can give relevant information. The aim of the present study
was to reveal potential molecular interactions between resveratrol and
lipid rafts found in cell membranes bymeans of Förster resonance energytransfer (FRET), DPHﬂuorescence quenching by TEMPO, and tritonX-100
detergent resistance assay. FRET has been successfully employed to
monitor lipid phase separations in model membranes [6,8], TEMPO is a
nitroxide-bearing quencher which binds to ld domains much more
strongly than to lo domains, therefore inducing a ﬂuidity-dependent
DPH quenching [17–19], and triton X-100 is a non-ionic detergent that
can be used to examine detergent-resistant membranes (DRMs) which
are composed of tight packing lipid rafts usually rich in sphingolipids
and cholesterol molecules [18,20]. This kind of methods has never been
applied before to study resveratrol interaction with membrane model
systems. For achieving this purpose, liposomes composed of egg L-α-
phosphatidylcholine (EPC), cholesterol (CHOL), and sphingomyelin
(SM) were used (Fig. 1). EPC is an egg yolk mixture of phosphatidylcho-
lineswhich are themost abundant lipids in cellmembranes [21–23]. Cho-
lesterol and sphingomyelin are essential components of the human cell
membranes [24,25], which undergo tight packing with phosphatidylcho-
lines [26,27], forming the so called lipid rafts [28–31]. According to the
umbrella model, the head groups of sphingomyelin molecules protect
the large nonpolar structures of cholesterol from the aqueous environ-
ment [28–30].
2. Materials and methods
2.1. Materials
trans-Resveratrol (N99% purity), egg L-α-phosphatidylcholine (EPC),
the quencher 2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPO) and triton
X-100 (TX-100) were obtained from Sigma-Aldrich (St. Louis, MO,
Fig. 1. Chemical structures of the intervenient species in this study. (A) trans-resveratrol; (B) cholesterol; (C) sphingomyelin predominant species— 33% and (D) egg phosphatidylcholine
(EPC) unsaturated predominant species — 31% 18:1 PC.
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dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) (DPPE-NBD) and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (DOPE-
Rhod) were purchased from Avanti Polar Lipids, Inc. (Alabama, USA).
The ﬂuorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH)was supplied
by Molecular Probes (Invitrogen Corporation, Carlsbad, California, USA).
Resveratrol solutions and lipid suspensions were prepared with phos-
phate buffer (pH 7.4). For the preparation of phosphate buffer solutions,
potassium phosphate monobasic was obtained from Sigma Aldrich and
sodium hydroxide from Riedel-de Haën AG (Seelze, Germany). The
buffers were prepared using double deionized water from arium
water puriﬁcation system (resistivity N18 MΩ cm, Sartorius, Goettingen,
Germany) and the ionic strength was adjusted to mimic physiological
conditions with NaCl (I = 0.1 M).
2.2. Liposomes preparation
Liposomes were prepared by the lipid ﬁlm hydration method [32,
33]. The molar ratio mixture of the lipids (EPC, EPC:CHOL [4:1],
or EPC:CHOL:SM [1:1:1]) was dissolved in chloroform/methanol (3:2,
v/v). The organic solvents were then evaporated by rotary evaporation
under a nitrogen stream to yield a dried lipid ﬁlm. The lipid ﬁlm was
hydrated with phosphate buffer (pH 7.4) and vortexed at 40 °C (well
above the main phase transition temperature of the lipids). The suspen-
sion of multilamellar vesicles (MLVs) was then extruded 10 times across
a polycarbonateﬁlterwith a pore size of 100 nm to form large unilamellar
vesicles (LUVs). For ﬂuorescence measurements, the probes were co-
dissolved with the lipids in the organic solvent mixture.
2.3. Förster resonance energy transfer
The use of FRET to characterize phase separation in membranes has
been well documented [7,8,34]. Accordingly, liposomes were labelled
with different combinations of probes: only the donor probe (DPPE-
NBD, 0.1 mol.%) or both the donor and acceptor probes (DPPE-NBD,
0.1 mol.% + DOPE-Rhod, 2 mol.%). The donor and acceptor probes
have preference for different membrane phases. Thus, DPPE-NBD parti-
tions preferably into lo domains and DOPE-Rhod partitions strongly intold phases [35]. The coexistence of ordered and disordered domains in
lipid bilayers causes the segregation of the donor and acceptor probes,
which results in FRET decrease.
Increasing concentrations of resveratrol (from 0 to 80 μM) were
incubated with labelled liposomes with a ﬁxed concentration of lipid
(500 μM), in phosphate buffer (pH 7.4). Samples were incubated in
the dark for 30min so that resveratrol could reach the partition equilib-
rium between the lipid membranes and the aqueous medium, at phys-
iological temperature (37 °C). Fluorescence intensity of the donor probe
was measured both in the presence and absence of the acceptor probe,
at 37 °C with excitation/emission wavelengths of 460/535 nm, by using
a Jasco FP6500 steady-state spectroﬂuorimeter equipped with a con-
stant temperature cell holder. FRET efﬁciency, E, was calculated using
the equation [34]:
E ¼ ID −ID−A
ID
ð1Þ
where ID is the donor ﬂuorescence intensity in the absence of the accep-
tor probe and ID − A is the donor ﬂuorescence intensity in the presence
of the acceptor probe.
2.4. Calculation of Ro and R distances by FRET analysis
Each pair of FRET probes can be characterized by a speciﬁc Förster
distance (R0), which corresponds to the distance at which the energy
transfer from the donor to the acceptor is 50% efﬁcient [36]. The mag-
nitude of R0 is dependent on the spectral properties of the donor and
acceptor dyes, but is also dependent on the lipid environment [37].
Therefore, the value of R0 (in Å) observed in eachmembranemodel sys-
tem for NBD/Rhodpair should be experimentally calculated through the
equation [38]:
R0 ¼ 9:78 103 k2n−4QD J λð Þ
h i1=6 ð2Þ
where k2 is the orientation factor (=2/3) between the transition
dipoles of the donor and acceptor, n represents the refractive index of
the medium (=1.361), QD is the quantum yield of the donor in the
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gral between the ﬂuorescence emission spectrum of the donor and the
absorption spectrumof the acceptorwhich is expressed inM−1 cm3 and
given by [38]:
J λð Þ ¼
Z
FD λð Þ:εA λð Þ:λ4dλ ð3Þ
where FD is the ﬂuorescence emission intensity of the donor normalized
as a fraction of the total integrated intensity, εA is the extinction coef-
ﬁcient of the acceptor expressed in M−1 cm−1 and λ is the wavelength
expressed in cm.
In order to study the effect of resveratrol on the domains formation in
lipid bilayers, the distance R that separates the donor from the acceptor
was calculated through the following equation, where R0 is the Förster
distance and E is the FRET efﬁciency [38]:
R ¼ R0 1−EE
 1=6
: ð4Þ
2.5. Fluorescence quenching of DPH by TEMPO
The ﬂuorescence quenching of DPH by the quencher TEMPO can be
used to study changes inmembrane ﬂuidity and particularly the forma-
tion of ordered domains, since TEMPO shows afﬁnity only for the disor-
dered ﬂuid phases [11]. Increasing concentrations of resveratrol (from 0
to 80 μM)were incubatedwith 0.3mol.% DPH labelled liposomeswith a
ﬁxed concentration of lipid (500 μM), in phosphate buffer (pH 7.4), for
30 min at 37 °C. For each resveratrol concentration, two different sam-
ples were prepared (FT and F0 samples). In FT samples, 10 μl of a
350 mM stock solution of TEMPO in ethanol was added to obtain a
ﬁnal concentration of 2 mM. The same volume of pure ethanol was
added to F0 samples in order to account for any possible effect of ethanol
on DPH ﬂuorescence intensity. The samples were incubated for 30 min,
at 37 °C and the DPH ﬂuorescence intensity (357/429 nm) was
measured at this temperature in a Jasco FP6500 steady-state spectroﬂu-
orimeter. The ﬂuorescence quenching effect of TEMPOwas given by the
ratio between DPH ﬂuorescence intensity in the presence of quencher
and in its absence (FT/F0) for each resveratrol concentration tested.
This ratio also allowed the elimination of the quenching effect of resver-
atrol, already reported in a recent study [39].
2.6. Membrane resistance against TX-100 detergent effect
In previous studies it has been observed that only ld domains can be
dissolved by TX-100, while lo rafts are resistant to detergent effect [40,
41]. In this context, the membrane resistance to TX-100 may provide ev-
idence for domains formation. The turbidity of liposome suspensions was
evaluated by measuring the absorbance at 500 nm and 37 °C in the ab-
sence and in the presence of 80 μM resveratrol, exposing the samples to
increasing concentrations of TX-100 (from 0 to 4 mol.%). Samples were
stirred before each measurement in a Jasco V-660 spectrophotometer.
The membrane resistance to detergent effect is given by the relative ab-
sorbancewhichwas normalized against the control turbidity value before
TX-100 addition.
3. Results and discussion
3.1. Resveratrol induces phase separation in lipid bilayers
Liposomes composed of EPC, EPC:CHOL [4:1] and EPC:CHOL:SM
[1:1:1] were labelled with the donor probe, DPPE-NBD (lo phase) and
the acceptor probe, DOPE-Rhod (ld phase). When FRET efﬁciency
decreases, this means a signiﬁcant increase in the distance between
the probes and, therefore, a potential separation between liquid-ordered domains and liquid-disordered phase [7,8,34]. In the absence
of resveratrol, the FRET efﬁciencywas 0.9, 0.7 and 0.4 for EPC, EPC:CHOL
and EPC:CHOL:SM, respectively (Fig. 2).
In fact, it is well known that cholesterol and sphingomyelin mole-
cules induce phase separation through the formation of ordered do-
mains in an umbrella conformation, where cholesterol is protected by
the head groups of sphingomyelin from the aqueous environment [26,
28,30]. In the presence of resveratrol, FRET efﬁciency was decreased
by 13% in EPC bilayers, 40% in EPC:CHOL membranes, and 100% in
EPC:CHOL:SM lipid model systems (Fig. 2), suggesting a slight phase
separation in pure EPC membranes, a signiﬁcant segregation of the or-
dered domains from the disordered phase in EPC:CHOL bilayers, and a
complete separation of the probes in the EPC:CHOL:SMmodel, after in-
cubation with 80 μM resveratrol. This result reﬂects a higher effect of
resveratrol in ordered domains, since this compound leads to a larger
phase separation in membranes rich in cholesterol and sphingomyelin
domains. Moreover, since the reduction of energy transfer in pure EPC
bilayers was very low, it is possible to state that resveratrol did not in-
terfere directly with the probes, and that the induction of phase separa-
tion in membranes with cholesterol and sphingomyelin did not result
from a direct ﬂuorescence quenching caused by the presence of resver-
atrol. FRET efﬁciency in the presence of increasing membrane effective
concentrations of resveratrol was also plotted in Supporting informa-
tion (Fig. S1), where it can be seen that a lower membranar concentra-
tion produces a greater effect on phase separation in a more ordered
membrane, such as the case of EPC:CHOL:SM.
As already said, R0 is the critical distance characteristic of a particular
donor/acceptor pair of FRET probes which is also dependent on the sur-
rounding lipid environment [37]. The R0 for DPPE-NBD/DOPE-Rhodwas
estimated to be between 45 Å and 70 Å [42,43] for different lipid model
systems, and more recently, FRET studies performed in POPC bilayers
have also shown an effective R0 of 49 Å [18]. Therefore, the R0 values
obtained in this study for each lipidmodel system (ca. 53 Å) is in agree-
ment with the literature (Table 1).
In the absence of resveratrol, the value of R distance between the
donor and the acceptor probes is ca. 37 Å, 46 Å and 57 Å for EPC,
EPC:CHOL and EPC:CHOL:SM models, respectively (Table 1). Hence, it
is possible to conﬁrm that the distance between the probes increases
when adding cholesterol and further increases in the presence of
sphingomyelin, which once again provides evidence that cholesterol
and sphingomyelin molecules induce phase separation in lipid bilayers.
Table 1 also shows that resveratrol induces the segregation of FRET
probes, since R distances increase 5 Å in pure EPC bilayer, 10 Å in
EPC:CHOL membranes and 70 Å in EPC:CHOL:SM model systems, upon
60 μM resveratrol concentration. The phase separation is softer for pure
EPC bilayer, but in the presence of cholesterol and sphingomyelin mole-
cules, resveratrol leads to a complete segregation of probes, thereby
avoiding FRET to occur.
3.2. Resveratrol prevents DPH quenching by TEMPO.
The FRET results suggested that resveratrol induced a lo–ld phase
separation, although the origin of this separation is not yet clear. In
fact, resveratrol may cause the formation of liquid-ordered domains
that segregate from the liquid-disordered phase, or alternatively, res-
veratrol can produce liquid-disordered domains to segregate from the
existing ordered phase. Therefore, it is of great importance to under-
stand resveratrol effect on membrane ﬂuidity and order, through a
DPH ﬂuorescence quenching assay using the quencher TEMPO. The
quenching is achieved through the partition of TEMPO into the disor-
dered ﬂuid domains where the hydrophobic DPH probe is localized
[11]. However, when tightly packed ordered domains are formed, the
quencher has no access toDPHand there is no quenching effect, thereby
increasing the DPH ﬂuorescence intensity ratio (FT/F0). This justiﬁes the
lower FT/F0 value for EPC bilayer (0.15), followed by EPC:CHOL (0.25)
and ﬁnally the highest value for the EPC:CHOL:SM membrane (0.35)
Fig. 2. Effect of resveratrol on FRET efﬁciency between DPPE-NBD (lo phase) and DOPE-
Rhod (ld phase) in LUVs of (A) EPC, (B) EPC:CHOL [4:1], and (C) EPC:CHOL:SM [1:1:1].
(*) denotes statistically signiﬁcant differences against the sample without resveratrol
(P b 0.05).
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of cholesterol and sphingomyelin hamper the access of the quench-
er TEMPO to DPH probe, reducing its ﬂuorescence quenching in the
EPC:CHOL:SM bilayer.
In Fig. 3, it is possible to see that resveratrol reduces the ﬂuorescence
quenching of DPH by the quencher TEMPO in EPC, EPC:CHOL and
EPC:CHOL:SM model systems, since it increases FT/F0 in 18%, 66% and
100%, respectively. Moreover, there seems to be a saturation effect
above 40 μM resveratrol for cholesterol-containing membranes and
above 50 μM for EPC. This behaviour can also be seen for FRET assays
(Fig. 2). This saturation effect can translate amaximum resveratrol:lipid
molar ratio in the membranes around 10 mol.%. Besides that, one can
conclude that resveratrol induces lo domains formation, which prevent
the interaction of the quencher with DPH probe. By this way, the phase
separation detected in FRET assays is justiﬁed by the segregation of lo
domains from the existing ld phase. This effect is much more pro-
nounced in the presence of cholesterol and sphingomyelin lipids, there-
by suggesting a higher stabilization or formation of ordered domains
associated with lipid rafts in biomembranes. On the contrary, this effect
was much less evident in pure EPC bilayers where TEMPO produced a
soft ﬂuorescence quenching of DPH, thereby showing that resveratrol
did not directly interfere with the quencher TEMPO. The quenching
effect of TEMPO in the presence of increasing membrane effective con-
centrations of resveratrol was also plotted in Supporting information
(Fig. S2).
3.3. Resveratrol increases membrane resistance to TX-100.
The membrane resistance assay allowed to quantify the detergent
effect of TX-100 on lipid bilayers, by measuring the lipid turbidity at
500 nm of liposomes suspensions in the absence and in the presence
of resveratrol. The resistance to TX-100 is characteristic of membrane
ordered domains [40,41].
The analysis of Fig. 4 suggested that 80 μMresveratrol induced a shift
of the curve in the presence of TX-100 in EPC:CHOL and EPC:CHOL:SM
models, showing that resveratrol promoted the formation of highly or-
dered domains which confer protection to the detergent effect on these
lipid bilayers. These results support the ﬁndings already obtained in
FRET analysis and in the DPH ﬂuorescence quenching assays using the
quencher TEMPO, indicating the formation of tightly packedmembrane
domains in the presence of resveratrol which induces phase separation.
Nevertheless, in the EPC bilayer, this effect was not observed (data
not shown) probably because the phase separation and formation of or-
dered domainswere not sufﬁcient to provide such detergent protection.
Moreover, the absence of detergent protection effect in pure EPC mem-
branes showed that the increase of turbidity in the lipid mixtures was
not caused by a direct interaction between resveratrol and TX-100 and
that this detergent resistance ofmembranes is not induced by the deter-
gent itself. Indeed, previous studies have indicated that detergents may
alter membrane properties, inducing phase separation and the forma-
tion of artiﬁcial membrane domains [44,45]. However, in this case, the
observed detergent resistance conferred by resveratrol in EPC:CHOL
and EPC:CHOL:SM model systems cannot be just ascribed to TX-100
effect, since in pure EPC bilayers this effect is not observed.
4. Conclusion
The main objective of this study was to elucidate the way by which
resveratrol exerts its wide variety of therapeutic properties, examining
the ability of this compound to alter membrane phase behaviour and
trying to correlate its interactionwith biological membraneswith its in-
ﬂuence in lipid domains formation.
In order to make sure if we can really achieve such resveratrol con-
centrations in vivo, a literature search was made. Previous studies
showed that a peak plasma level of≈2 μM is reached after oral admin-
istration of 25 mg of resveratrol by a 70 kg individual [1]. Moreover,
Table 1
Förster distances (R0) at which energy transfer efﬁciency is 50% and the effect of resveratrol concentration on the distances (R) between the donor (DPPE-NBD, lo phase) and the acceptor
(DOPE-Rhod, ld phase) probes, in LUVs of EPC, EPC:CHOL [4:1], and EPC:CHOL:SM [1:1:1].
System R0/Å (NBD/Rhod)
R/Å
0 μM 20 μM 40 μM 60 μM 80 μM
EPC 52.5 ± 1.1 36.6 ± 0.5 35.3 ± 0.3 38.0 ± 0.5 42.0 ± 0.3 42.4 ± 0.2
EPC:CHOL [4:1] 53.1 ± 0.5 46.2 ± 0.6 51.2 ± 0.4 55.8 ± 0.3 56.8 ± 0.2 56.1 ± 0.5
EPC:CHOL:SM [1:1:1] 53.6 ± 0.7 57.4 ± 0.4 86.4 ± 0.6 125.7 ± 0.8 128.6 ± 0.9 NDa
a ND— no data available for this concentration since FRET efﬁciency was equal to 0.
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verse effects at doses of 500 mg per day [2]. Therefore, a level of ca.
40 μM resveratrol can be achieved in the plasma after oral administra-
tion of a 500 mg resveratrol supplement, which is comparable withFig. 3. Effect of resveratrol on DPH ﬂuorescence quenching by the quencher TEMPO in
LUVs of (A) EPC, (B) EPC:CHOL [4:1], and (C) EPC:CHOL:SM [1:1:1]. (*) denotes statistically
signiﬁcant differences against the sample without resveratrol (P b 0.05).the concentrations used in this study that produced the maximum
effect.
The results revealed that resveratrol induces phase separation,
stabilizing and promoting the formation of lo domains in EPC, EPC:CHOL
[4:1] and EPC:CHOL:SM [1:1:1] bilayers. FRET results have shown a softer
phase separation for pure EPC bilayer, but a complete segregation of
probes in the presence of cholesterol and sphingomyelin molecules. The
phase separation detected in FRET was justiﬁed by the segregation of lo
domains from the existing ld phase, as shown by the decrease of DPH
quenching effect of TEMPO and the increase of TX-100 detergent-
resistance of lipid bilayers. Indeed, resveratrol induces lo domains forma-
tion, thereby favouring the tightly packed lipid rafts [46,47], especially in
cholesterol- and sphingomyelin-rich membranes.
Fig. 5 shows a schematic representation of the proposed effect of
resveratrol in domains formation and stabilization in the studied mem-
brane bilayers. A recent study showed the location of resveratrol in
different membrane model systems by ﬂuorescence quenching of probes
with well-knownmembrane positions [39]. Resveratrol is mainly located
in a deeper region of the membrane, establishing interactions with the
phospholipid tails [39]. Therefore,we suggest a vertical position of resver-
atrol in a nonpolar region of themembrane, with two hydroxyl groups in
the interface.Fig. 4. Effect of resveratrol on the resistance of membranes against detergent effect of
triton X-100 in LUVs of (A) EPC:CHOL [4:1] and (B) EPC:CHOL:SM [1:1:1].
Fig. 5. Schematic representation of the proposed effect of resveratrol in domains formation and stabilization in membrane bilayers of (A) EPC, (B) EPC:CHOL [4:1], and (C) EPC:CHOL:SM
[1:1:1]. Note: water molecules are not represented for simpliﬁcation.
17A.R. Neves et al. / Biochimica et Biophysica Acta 1858 (2016) 12–18The formation of such ordered domains is important for different
signal transduction pathways, through the regulation of membrane-
associating receptors, proteins and enzymes [48,49]. For instance, lipid
rafts have been associated to organizing centres for the assembly of
apoptotic and signalling molecules involved in cell death [50–55].
Moreover, several receptors involved in neurological functions, such
as α7 nicotinic acetylcholine receptors, were found to be localized into
lipid rafts and the disruption of their lipid structure may result in signif-
icant changes and receptors desensitization [56–59]. Therefore, the con-
ﬁrmation that rafts are targeted and stabilized by resveratrolmay justify
its several pharmacological activities, such as neuroprotection and can-
cer chemoprevention, through the regulation of cellular events such as
neurotransmitter release, second messenger cascades and cell survival.
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